Low HLA-DR expression on peripheral blood monocytes predicts bacterial sepsis after liver transplantation: relation with prednisolone intake

Transpl Infect Dis. 1999 Sep;1(3):146-52. doi: 10.1034/j.1399-3062.1999.010302.x.

Abstract

Bacterial sepsis remains a frequent complication after liver transplantation. We previously reported the results of a pilot study that suggested that low expression of HLA-DR on monocytes is a predictive marker for the occurrence of sepsis. We have studied the value of this marker in an additional cohort of patients, and have analyzed the relation of HLA-DR expression with the use of immunosuppressive agents. 20 adult liver transplantation patients were prospectively monitored during the first 4 weeks after transplantation. All were treated according to standard protocols. The percentage of monocytes expressing HLA-DR was measured by flow cytometry. In addition, the effects of incubation of monocytes with prednisolone in vitro on the expression of HLA-DR was determined in 7 healthy volunteers. Seven patients developed bacterial sepsis after a median 15 (range 10-20) days after transplantation. HLA-DR expression was significantly lower in these patients on days 7, 14, 21, and 28 after transplantation compared with non-septic patients. The percentage of HLA-DR positive monocytes was 30% or less, 3 (1-8) days before onset of sepsis. On day 7 after transplantation, HLA-DR expression on 50% or less of monocytes had a positive predictive value for sepsis of 71%, whereas the negative predictive value was 85%. Patients who developed sepsis received significantly more prednisolone. Incubation with prednisolone in vitro lowered the expression of HLA-DR in a dose-dependent manner. We conclude that low HLA-DR expression on monocytes is a marker for a high risk of subsequent sepsis in liver transplantation patients. This high risk may be (at least partly) related to the dose of prednisolone.

MeSH terms

  • Adolescent
  • Adult
  • Amphotericin B / therapeutic use
  • Anti-Bacterial Agents / therapeutic use
  • Bacterial Infections / drug therapy
  • Bacterial Infections / epidemiology*
  • Bacterial Infections / immunology
  • Biomarkers / blood*
  • Drug Therapy, Combination
  • Female
  • HLA-DR Antigens / blood*
  • Humans
  • Immunosuppression Therapy / methods
  • Immunosuppressive Agents / therapeutic use
  • Liver Transplantation / immunology*
  • Liver Transplantation / physiology
  • Lymphocytes / immunology*
  • Male
  • Middle Aged
  • Monitoring, Immunologic
  • Postoperative Complications*
  • Predictive Value of Tests
  • Prospective Studies
  • Sepsis / drug therapy
  • Sepsis / epidemiology*
  • Sepsis / immunology

Substances

  • Anti-Bacterial Agents
  • Biomarkers
  • HLA-DR Antigens
  • Immunosuppressive Agents
  • Amphotericin B